Our dedicated team of medical professionals is here to guide you every step of the way, ensuring personalized care that leads to real, lasting results
A 2025 review characterized retatrutide's up-to-24% weight loss at 48 weeks as a step-change versus prior incretin therapies [6]
Takeda acquired ex-China rights to fruquintinib, a VEGFR-1, VEGFR-2 and VEGFR-3 inhibitor, from Hutchmed China Ltd
When several studies start to point in the same direction, it becomes hard to dismiss as coincidence or isolated patient experiences
Risks & Safety Concerns Glutathione injections must always be administered by a qualified medical professional, ideally in a dermatology clinic or healthcare setting
Ask about adding VOL.U.LIFT to your skincare routine at your next appointment